Table 1.
Demographic, clinical and biochemical characteristics of study patients.
| Parameters | |
|---|---|
| Age (years) | 51.37±15.95 |
| Gender (M/F) | 40/37 |
| Dialysis vintage (months) | 60.51±17.67 |
| Diabetes (%) | 13 (16.8%) |
| Hypertension (%) | 28 (36.3%) |
| Smoking (%) | 25 (32.4%) |
| AVF/Permanetcatheter | 61/16 |
| Body mass index (kg/m2) | 23.96±5.65 |
| Residual urine (l/day) | 0.02±0.01 |
| Ultrafiltration volume (ml) | 2400.44±417.96 |
| Duration delivered (hours) | 5.0 |
| Antihypertensive treatment (%) | 28.33% |
| PTH (pg/ml) | 377.5 (5.5–2689) |
| CRP (mg/dl) | 1.36±0.48 |
| Albumin (g/dl, pre-HD) | 3.33±0.35 |
| Haemoglobin (g/dl, pre-HD) | 11.76±1.67 |
| Calcium (mg/dl, pre-HD) | 8.14±0.95 |
| Phosphorus (mg/dl, pre-HD) | 4.84±1.28 |
| CaxP product (mg2/dl2) | 39.65±11.86 |
| Urea reduction ratio (%) | 76.52±5.59 |
| Kt/V | 1.49±0.25 |
AVF – arteriovenous fistula; PTH – parathyroid hormone; CRP – C-reactive protein; Ca – calcium; P – phosphorus.